<p>Arrowstreet Capital Limited Partnership 在最近向證券交易委員會的披露中表示，在第二季度將其在 Concentrix Corporation (NASDAQ:CNXC - 免費報告) 的持股增加了 247.2%。該公司在此期間額外購買了 381,497 股，持有 535,843 股。Arrowstreet Capital Limited Partnership 在最近的報告期末持有 Concentrix 約 0.85% 的股份，價值 28,322,000 美元。</p>
<ul>
<li>Concentrix：高負債和掙扎的利潤率</li>
</ul>
<p>其他幾家大型投資者最近也調整了他們對 CNXC 的持股。Geneos Wealth Management Inc. 在第一季度將其在 Concentrix 的持股增加了 532.7%。Geneos Wealth Management Inc. 現在擁有 620 股該公司的股票，價值 34,000 美元，此前在此期間額外購買了 522 股。IFP Advisors Inc 在第二季度將其在 Concentrix 的持股增加了 473.8%。IFP Advisors Inc 現在擁有 700 股該公司的股票，價值 37,000 美元，此前在上個季度額外購買了 578 股。True Wealth Design LLC 在第二季度將其在 Concentrix 的持股增加了 39.3%。True Wealth Design LLC 現在擁有 1,163 股該公司的股票，價值 61,000 美元，此前在此期間額外購買了 328 股。PNC Financial Services Group Inc. 在第一季度將其在 Concentrix 的持股增加了 47.3%。PNC Financial Services Group Inc. 現在擁有 1,504 股該公司的股票，價值 84,000 美元，此前在此期間額外購買了 483 股。最後，Parkside Financial Bank &amp; Trust 在第二季度將其在 Concentrix 的持股增加了 23.9%。Parkside Financial Bank &amp; Trust 現在擁有 1,818 股該公司的股票，價值 96,000 美元，此前在上個季度額外購買了 351 股。對沖基金和其他機構投資者持有該公司 90.34% 的股票。</p>
<h2>Concentrix 股價上漲 1.8%</h2>
<p>NASDAQ:CNXC 週五開盤價為 37.61 美元。該公司的 50 日移動平均價格為 40.83 美元，200 日移動平均價格為 49.45 美元。該股票的市值為 23.4 億美元，市盈率為 7.95，市盈增長比率為 0.50，貝塔係數為 0.50。該公司的流動比率為 1.56，速動比率為 1.56，債務與股本比率為 1.10。Concentrix Corporation 的 12 個月低點為 31.63 美元，12 個月高點為 66.00 美元。</p>
<p>Concentrix (NASDAQ:CNXC - 獲取免費報告) 最近在 9 月 25 日星期四公佈了季度財報。該公司報告每股收益 (EPS) 為 2.78 美元，低於市場共識預期的 2.88 美元，差額為 0.10 美元。Concentrix 的淨利潤率為 3.25%，股本回報率為 16.02%。該公司在本季度的收入為 24.8 億美元，而分析師預期為 24.6 億美元。在去年同期，該公司每股收益為 2.87 美元。與去年同期相比，Concentrix 的季度收入增長了 4.0%。Concentrix 將其 2025 財年的指導目標設定為每股收益 11.110-11.230 美元，2025 年第四季度的指導目標為每股收益 2.850-2.960 美元。股票分析師預測 Concentrix Corporation 今年將發佈每股收益 10.11 美元。</p>
<h2>Concentrix 增加股息</h2>
<p>該公司最近還宣佈了一項季度股息，於 11 月 4 日星期二支付。10 月 24 日的股東獲得了 0.36 美元的股息。該股息的除息日期為 10 月 24 日。這代表着年化股息為 1.44 美元，股息收益率為 3.8%。這比 Concentrix 之前的季度股息 0.33 美元有所增加。Concentrix 的股息支付比率目前為 30.44%。</p>
<h2>分析師設定新目標價</h2>
<p>一些股票研究分析師最近對 CNXC 股票發表了評論。Weiss Ratings 在 10 月 8 日星期三的報告中將 Concentrix 的股票評級從 &#34;賣出 (d+)&#34; 上調至 &#34;持有 (c-)&#34;。Barrington Research 在 11 月 20 日星期四重申了 &#34;跑贏大盤&#34; 的評級，並對 Concentrix 的股票設定了 62.00 美元的目標價。Canaccord Genuity Group 在 9 月 23 日星期二的報告中重申了 &#34;買入&#34; 的評級，並設定了 80.00 美元的目標價。Wall Street Zen 在 10 月 25 日星期六的研究報告中將 Concentrix 的評級從 &#34;持有&#34; 上調至 &#34;買入&#34;。最後，Robert W. Baird 在 9 月 29 日星期一的研究報告中將 Concentrix 的目標價從 75.00 美元下調至 62.00 美元，並對該公司設定了 &#34;跑贏大盤&#34; 的評級。三位分析師對該股票給予了買入評級，兩位分析師對該公司的股票給予了持有評級。根據 MarketBeat.com 的數據，該股票的共識評級為 &#34;適度買入&#34;，共識目標價為 66.25 美元。</p>
<p><strong>查看我們關於 CNXC 的最新報告</strong></p>
<h2>Concentrix 的內部活動</h2>
<p>在其他新聞中，首席執行官 Christopher A. Caldwell 在 10 月 30 日星期四的交易中購買了 2,000 股該股票。該股票的平均購買價格為每股 42.03 美元，總交易額為 84,060.00 美元。購買後，首席執行官直接持有該公司 286,661 股，價值 12,048,361.83 美元。這筆交易代表了其持股的 0.70% 增加。該購買在向證券交易委員會的法律文件中披露，可以通過 SEC 網站訪問。在過去三個月中，內部人士購買了價值 169,410 美元的 4,000 股公司股票。公司內部人士持有該公司 3.20% 的股票。</p>
<h2>關於 Concentrix</h2>
<p>(免費報告)</p>
<p>Concentrix Corporation 從事全球範圍內的技術驅動客户體驗 (CX) 解決方案的提供。該公司提供 CX 流程優化、技術創新、前台和後台自動化、分析和業務轉型服務，涵蓋語音、聊天、電子郵件、社交媒體、異步消息和定製應用等多種溝通渠道。</p>
<h2>相關文章</h2>
<ul>
<li>我們更看好的五隻股票</li>
<li>ETF 是否支付股息？你需要知道的事項</li>
<li>Ulta 的股票可能會迎來大幅上漲——未來有 20% 的上漲空間？</li>
<li>如何交易便士股票：逐步指南</li>
<li>比爾和梅琳達·蓋茨基金會出售 MSFT 股票——投資者應該擔心嗎？</li>
<li>投資建築類股票</li>
<li>MarketBeat 周度回顧 – 12/1 - 12/5</li>
</ul>
<p><strong>想看看其他對 CNXC 持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取 Concentrix Corporation (NASDAQ:CNXC - 免費報告) 的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q05YQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q05YQw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Concentrix 嗎？</h2>
<p>在考慮 Concentrix 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Concentrix 並不在名單上。</p>
<p>雖然 Concentrix 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

CNXC

<p>Arrowstreet Capital Limited Partnership 在第二季度增持了 Concentrix Corporation 的股份，增幅達到 247.2%，共購入 381,497 股。該公司目前持有 Concentrix 0.85% 的股份，價值 2832 萬美元。分析師對 Concentrix 的股票進行了評級，有些分析師將其評級上調至 “買入”，而其他分析師則維持 “持有” 評級。該公司報告了第三季度每股收益為 2.78 美元，未達到預期，並宣佈將每股股息提高至 0.36 美元</p>

<p>Arrowstreet Capital Limited Partnership raised its holdings in shares of Concentrix Corporation (NASDAQ:CNXC - Free Report) by 247.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The firm owned 535,843 shares of the company's stock after buying an additional 381,497 shares during the period. Arrowstreet Capital Limited Partnership owned about 0.85% of Concentrix worth $28,322,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Arrowstreet Capital Limited Partnership 在最近向證券交易委員會的披露中表示，在第二季度將其在 Concentrix Corporation (NASDAQ:CNXC - 免費報告) 的持股增加了 247.2%。該公司在此期間額外購買了 381,497 股，持有 535,843 股。Arrowstreet Capital Limited Partnership 在最近的報告期末持有 Concentrix 約 0.85% 的股份，價值 28,322,000 美元。</p>
</div><ul>
<li>Concentrix: High Debt and Struggling Margins</li>
</ul>
<div class="lb-trans"><ul>
<li>Concentrix：高負債和掙扎的利潤率</li>
</ul>
</div><p>Several other large investors have also recently modified their holdings of CNXC. Geneos Wealth Management Inc. boosted its holdings in Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock valued at $34,000 after acquiring an additional 522 shares during the period. IFP Advisors Inc lifted its position in Concentrix by 473.8% in the second quarter. IFP Advisors Inc now owns 700 shares of the company's stock valued at $37,000 after purchasing an additional 578 shares during the last quarter. True Wealth Design LLC boosted its stake in shares of Concentrix by 39.3% during the second quarter. True Wealth Design LLC now owns 1,163 shares of the company's stock valued at $61,000 after purchasing an additional 328 shares during the period. PNC Financial Services Group Inc. boosted its stake in shares of Concentrix by 47.3% during the first quarter. PNC Financial Services Group Inc. now owns 1,504 shares of the company's stock valued at $84,000 after purchasing an additional 483 shares during the period. Finally, Parkside Financial Bank &amp; Trust grew its holdings in shares of Concentrix by 23.9% in the second quarter. Parkside Financial Bank &amp; Trust now owns 1,818 shares of the company's stock worth $96,000 after purchasing an additional 351 shares during the last quarter. Hedge funds and other institutional investors own 90.34% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家大型投資者最近也調整了他們對 CNXC 的持股。Geneos Wealth Management Inc. 在第一季度將其在 Concentrix 的持股增加了 532.7%。Geneos Wealth Management Inc. 現在擁有 620 股該公司的股票，價值 34,000 美元，此前在此期間額外購買了 522 股。IFP Advisors Inc 在第二季度將其在 Concentrix 的持股增加了 473.8%。IFP Advisors Inc 現在擁有 700 股該公司的股票，價值 37,000 美元，此前在上個季度額外購買了 578 股。True Wealth Design LLC 在第二季度將其在 Concentrix 的持股增加了 39.3%。True Wealth Design LLC 現在擁有 1,163 股該公司的股票，價值 61,000 美元，此前在此期間額外購買了 328 股。PNC Financial Services Group Inc. 在第一季度將其在 Concentrix 的持股增加了 47.3%。PNC Financial Services Group Inc. 現在擁有 1,504 股該公司的股票，價值 84,000 美元，此前在此期間額外購買了 483 股。最後，Parkside Financial Bank &amp; Trust 在第二季度將其在 Concentrix 的持股增加了 23.9%。Parkside Financial Bank &amp; Trust 現在擁有 1,818 股該公司的股票，價值 96,000 美元，此前在上個季度額外購買了 351 股。對沖基金和其他機構投資者持有該公司 90.34% 的股票。</p>
</div><h2>Concentrix Trading Up 1.8%</h2>
<div class="lb-trans"><h2>Concentrix 股價上漲 1.8%</h2>
</div><p>NASDAQ:CNXC opened at $37.61 on Friday. The company has a 50-day moving average price of $40.83 and a 200-day moving average price of $49.45. The stock has a market cap of $2.34 billion, a price-to-earnings ratio of 7.95, a P/E/G ratio of 0.50 and a beta of 0.50. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 1.10. Concentrix Corporation has a 12 month low of $31.63 and a 12 month high of $66.00.</p>
<div class="lb-trans"><p>NASDAQ:CNXC 週五開盤價為 37.61 美元。該公司的 50 日移動平均價格為 40.83 美元，200 日移動平均價格為 49.45 美元。該股票的市值為 23.4 億美元，市盈率為 7.95，市盈增長比率為 0.50，貝塔係數為 0.50。該公司的流動比率為 1.56，速動比率為 1.56，債務與股本比率為 1.10。Concentrix Corporation 的 12 個月低點為 31.63 美元，12 個月高點為 66.00 美元。</p>
</div><p>Concentrix (NASDAQ:CNXC - Get Free Report) last announced its quarterly earnings results on Thursday, September 25th. The company reported $2.78 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.88 by ($0.10). Concentrix had a net margin of 3.25% and a return on equity of 16.02%. The company had revenue of $2.48 billion for the quarter, compared to analysts' expectations of $2.46 billion. During the same quarter in the prior year, the firm earned $2.87 EPS. Concentrix's quarterly revenue was up 4.0% compared to the same quarter last year. Concentrix has set its FY 2025 guidance at 11.110-11.230 EPS and its Q4 2025 guidance at 2.850-2.960 EPS. Equities analysts predict that Concentrix Corporation will post 10.11 EPS for the current year.</p>
<div class="lb-trans"><p>Concentrix (NASDAQ:CNXC - 獲取免費報告) 最近在 9 月 25 日星期四公佈了季度財報。該公司報告每股收益 (EPS) 為 2.78 美元，低於市場共識預期的 2.88 美元，差額為 0.10 美元。Concentrix 的淨利潤率為 3.25%，股本回報率為 16.02%。該公司在本季度的收入為 24.8 億美元，而分析師預期為 24.6 億美元。在去年同期，該公司每股收益為 2.87 美元。與去年同期相比，Concentrix 的季度收入增長了 4.0%。Concentrix 將其 2025 財年的指導目標設定為每股收益 11.110-11.230 美元，2025 年第四季度的指導目標為每股收益 2.850-2.960 美元。股票分析師預測 Concentrix Corporation 今年將發佈每股收益 10.11 美元。</p>
</div><h2>Concentrix Increases Dividend</h2>
<div class="lb-trans"><h2>Concentrix 增加股息</h2>
</div><p>The company also recently announced a quarterly dividend, which was paid on Tuesday, November 4th. Stockholders of record on Friday, October 24th were given a $0.36 dividend. The ex-dividend date of this dividend was Friday, October 24th. This represents a $1.44 annualized dividend and a dividend yield of 3.8%. This is an increase from Concentrix's previous quarterly dividend of $0.33. Concentrix's dividend payout ratio is currently 30.44%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度股息，於 11 月 4 日星期二支付。10 月 24 日的股東獲得了 0.36 美元的股息。該股息的除息日期為 10 月 24 日。這代表着年化股息為 1.44 美元，股息收益率為 3.8%。這比 Concentrix 之前的季度股息 0.33 美元有所增加。Concentrix 的股息支付比率目前為 30.44%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>A number of equities research analysts recently commented on CNXC shares. Weiss Ratings upgraded shares of Concentrix from a &#34;sell (d+)&#34; rating to a &#34;hold (c-)&#34; rating in a report on Wednesday, October 8th. Barrington Research restated an &#34;outperform&#34; rating and issued a $62.00 price objective on shares of Concentrix in a research report on Thursday, November 20th. Canaccord Genuity Group reiterated a &#34;buy&#34; rating and set a $80.00 target price on shares of Concentrix in a report on Tuesday, September 23rd. Wall Street Zen raised Concentrix from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Saturday, October 25th. Finally, Robert W. Baird lowered their price target on Concentrix from $75.00 to $62.00 and set an &#34;outperform&#34; rating for the company in a research report on Monday, September 29th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $66.25.</p>
<div class="lb-trans"><p>一些股票研究分析師最近對 CNXC 股票發表了評論。Weiss Ratings 在 10 月 8 日星期三的報告中將 Concentrix 的股票評級從 &#34;賣出 (d+)&#34; 上調至 &#34;持有 (c-)&#34;。Barrington Research 在 11 月 20 日星期四重申了 &#34;跑贏大盤&#34; 的評級，並對 Concentrix 的股票設定了 62.00 美元的目標價。Canaccord Genuity Group 在 9 月 23 日星期二的報告中重申了 &#34;買入&#34; 的評級，並設定了 80.00 美元的目標價。Wall Street Zen 在 10 月 25 日星期六的研究報告中將 Concentrix 的評級從 &#34;持有&#34; 上調至 &#34;買入&#34;。最後，Robert W. Baird 在 9 月 29 日星期一的研究報告中將 Concentrix 的目標價從 75.00 美元下調至 62.00 美元，並對該公司設定了 &#34;跑贏大盤&#34; 的評級。三位分析師對該股票給予了買入評級，兩位分析師對該公司的股票給予了持有評級。根據 MarketBeat.com 的數據，該股票的共識評級為 &#34;適度買入&#34;，共識目標價為 66.25 美元。</p>
</div><p><strong>View Our Latest Report on CNXC</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 CNXC 的最新報告</strong></p>
</div><h2>Insider Activity at Concentrix</h2>
<div class="lb-trans"><h2>Concentrix 的內部活動</h2>
</div><p>In other news, CEO Christopher A. Caldwell bought 2,000 shares of the stock in a transaction dated Thursday, October 30th. The stock was bought at an average price of $42.03 per share, for a total transaction of $84,060.00. Following the purchase, the chief executive officer directly owned 286,661 shares in the company, valued at $12,048,361.83. This trade represents a 0.70% increase in their position. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. In the last three months, insiders purchased 4,000 shares of company stock valued at $169,410. Company insiders own 3.20% of the company's stock.</p>
<div class="lb-trans"><p>在其他新聞中，首席執行官 Christopher A. Caldwell 在 10 月 30 日星期四的交易中購買了 2,000 股該股票。該股票的平均購買價格為每股 42.03 美元，總交易額為 84,060.00 美元。購買後，首席執行官直接持有該公司 286,661 股，價值 12,048,361.83 美元。這筆交易代表了其持股的 0.70% 增加。該購買在向證券交易委員會的法律文件中披露，可以通過 SEC 網站訪問。在過去三個月中，內部人士購買了價值 169,410 美元的 4,000 股公司股票。公司內部人士持有該公司 3.20% 的股票。</p>
</div><h2>About Concentrix</h2>
<div class="lb-trans"><h2>關於 Concentrix</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.</p>
<div class="lb-trans"><p>Concentrix Corporation 從事全球範圍內的技術驅動客户體驗 (CX) 解決方案的提供。該公司提供 CX 流程優化、技術創新、前台和後台自動化、分析和業務轉型服務，涵蓋語音、聊天、電子郵件、社交媒體、異步消息和定製應用等多種溝通渠道。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>相關文章</h2>
</div><ul>
<li>Five stocks we like better than Concentrix</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?</li>
<li>How to trade penny stocks: A step-by-step guide</li>
<li>Gates Foundation Sells MSFT Stock—Should Investors Be Worried?</li>
<li>Investing in Construction Stocks</li>
<li>MarketBeat Week in Review – 12/1 - 12/5</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票</li>
<li>ETF 是否支付股息？你需要知道的事項</li>
<li>Ulta 的股票可能會迎來大幅上漲——未來有 20% 的上漲空間？</li>
<li>如何交易便士股票：逐步指南</li>
<li>比爾和梅琳達·蓋茨基金會出售 MSFT 股票——投資者應該擔心嗎？</li>
<li>投資建築類股票</li>
<li>MarketBeat 周度回顧 – 12/1 - 12/5</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding CNXC?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXC - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 CNXC 持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取 Concentrix Corporation (NASDAQ:CNXC - 免費報告) 的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q05YQw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=CNXC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Concentrix Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Concentrix 嗎？</h2>
</div><p>Before you consider Concentrix, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Concentrix 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Concentrix 並不在名單上。</p>
</div><p>While Concentrix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Concentrix 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Arrowstreet Capital Limited Partnership 收購了 381,497 股 Concentrix Corporation $CNXC